The anti-metastatic efficacy of β-ionone and the possible mechanisms of action in human hepatocarcinoma SK-Hep-1 cells
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The anti-metastatic efficacy of β-ionone and the possible mechanisms of action in human hepatocarcinoma SK-Hep-1 cells
Authors
Keywords
-
Journal
BRITISH JOURNAL OF NUTRITION
Volume 107, Issue 05, Pages 631-638
Publisher
Cambridge University Press (CUP)
Online
2011-07-26
DOI
10.1017/s0007114511003473
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Hexane–ethanol extract of Glycyrrhiza uralensis containing licoricidin inhibits the metastatic capacity of DU145 human prostate cancer cells
- (2010) So Young Park et al. BRITISH JOURNAL OF NUTRITION
- The suppressor of metastasis Nm23-H1 interacts with the Cdc42 Rho family member and the pleckstrin homology domain of oncoprotein Dbl-1 to suppress cell migration
- (2010) Masanao Murakami et al. CANCER BIOLOGY & THERAPY
- The in vitro and in vivo anti-metastatic efficacy of oxythiamine and the possible mechanisms of action
- (2010) Chih-Min Yang et al. CLINICAL & EXPERIMENTAL METASTASIS
- Anti-metastatic activities of Antrodia camphorata against human breast cancer cells mediated through suppression of the MAPK signaling pathway
- (2010) Hsin-Ling Yang et al. FOOD AND CHEMICAL TOXICOLOGY
- Chemopreventive effects of β-ionone and geraniol during rat hepatocarcinogenesis promotion: distinct actions on cell proliferation, apoptosis, HMGCoA reductase, and RhoA
- (2010) Mônica Testoni Cardozo et al. JOURNAL OF NUTRITIONAL BIOCHEMISTRY
- β-Ionone Enhances TRAIL-Induced Apoptosis in Hepatocellular Carcinoma Cells through Sp1-Dependent Upregulation of DR5 and Downregulation of NF-κB Activity
- (2010) Mun-Ock Kim et al. MOLECULAR CANCER THERAPEUTICS
- Characterisation of fibronectin-mediated FAK signalling pathways in lung cancer cell migration and invasion
- (2009) X N Meng et al. BRITISH JOURNAL OF CANCER
- Role of DLC-1, a tumor suppressor protein with RhoGAP activity, in regulation of the cytoskeleton and cell motility
- (2009) T. Y. Kim et al. CANCER AND METASTASIS REVIEWS
- Signal transduction by focal adhesion kinase in cancer
- (2009) Jihe Zhao et al. CANCER AND METASTASIS REVIEWS
- The Urokinase Plasminogen Activator System: A Target for Anti-Cancer Therapy
- (2009) Salvatore Ulisse et al. CURRENT CANCER DRUG TARGETS
- Liver expression of matrix metalloproteases and their inhibitors in hepatocellular carcinoma
- (2009) A. Altadill et al. DIGESTIVE AND LIVER DISEASE
- Role and significance of focal adhesion proteins in hepatocellular carcinoma
- (2009) Judy Wai Ping Yam et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Role of nm23 in the regulation of cell shape and migration via Rho family GTPase signals
- (2009) Masaaki Miyamoto et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- β-Ionone-induced apoptosis in human osteosarcoma (U2os) cells occurs via a p53-dependent signaling pathway
- (2009) Jiang Zhu et al. MOLECULAR BIOLOGY REPORTS
- Carnosic acid prevents the migration of human aortic smooth muscle cells by inhibiting the activation and expression of matrix metalloproteinase-9
- (2008) Ya-Mei Yu et al. BRITISH JOURNAL OF NUTRITION
- β-Ionone suppresses mammary carcinogenesis, proliferative activity and induces apoptosis in the mammary gland of the Sprague-Dawley rat
- (2008) Jia-Ren Liu et al. INTERNATIONAL JOURNAL OF CANCER
- -Ionone inhibits colonic aberrant crypt foci formation in rats, suppresses cell growth, and induces retinoid X receptor- in human colon cancer cells
- (2008) N. B. Janakiram et al. MOLECULAR CANCER THERAPEUTICS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started